Doug Loe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Doug loe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Doug Loe Today - Breaking & Trending Today

Leede still bullish on Theratechnologies following "soft" quarter

After what he calls a “soft” first quarter, Leede Jones Gable analyst Doug Loe has maintained his “Speculative Buy” rating on Theratechnologies ....

Leede Jones Gable , Egrifta Trogarzo , Paul Levesque , Doug Loe , Theratechnologies Stock Quote , Speculative Buy ,

CRRX will benefit from Ontario's decision, Leede says

A change in policy from the Ontario government is a positive for CareRx , says Leede Jones Gable analyst Doug Loe. ....

Doug Loe , Leede Jones Gable , Puneet Khanna , Carerx Stock Quote , Drug Benefit Act ,

EXE stock wins price target raise at Leede Jones Gable

Its fourth quarter results are in the books and Leede Jones Gable analyst Doug Loe is feeling more bullish about Extendicare ....

Leede Jones Gable , Michael Guerriere , Doug Loe , Extendicare Stock Quote ,

Cipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q2 2022 Results - Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q2 2022 Earnings Conference Call August 12, 2022, 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille -. ....

United States , Sun Pharma , Scott Langille , Doug Loe , Mike Schimek , David Miller , Leede Jones Gable , Sun Pharmas , Peter Raytec , Company Participants , Cipher Pharmaceuticals Inc , Research Capital , Health Canada , Symphony Health , Cipher Pharmaceuticals , Conference Call August , Chief Executive , Leede Jones , South America , Latin American , South American , Craig Mull ,

Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated

The Globe and Mail
Bookmark
Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file .
This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Geoff Robins/The Globe and Mail
A tiny London, Ont., medical device company hoping to change how diabetes is treated has had a wild ride of late. Last Friday, stock in Sernova Corp. shot up 65 per cent on the TSX Venture Exchange, then nearly doubled on Monday, closing at $2.42 a share. At its peak, Sernova had a market capitalization of $630-million, making it one of Canada’s 15 most valuable publicly traded life sciences companies. ....

United States , United Kingdom , City Of , Philip Toleikis , Doug Loe , Scott Mcauley , Frederick Banting , David Prowten , Leede Jones Gable , Piotr Witkowski , James Collip , Geoff Robins , Michael May , Novo Nordisk , University Of Alberta , Diabetes Research Foundation Canada , Drug Administration , Centre For Commercialization Of Regenerative Medicine , Eli Lilly Co , University Of British Columbia , Sernova Corp , Venture Exchange , American Society Of Transplant Surgeons , Western University , Sigilon Therapeutics , Sana Therapeutics ,